Pfizer to discontinue development programme for PF-07265803 for LMNA-related dilated cardiomyopathy Read more
Impact of COVID-19 on pharma formulation: Bhupendra Pratap Singh Chauhan, CQA Head, Morepen Laboratories Read more
Aseptic BioProcess Equipment Manufacturer: NVS Vishal, Business Development Executive, Omega Scientific Instruments Read more
EU approves AstraZeneca’s Lynparza for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer Read more
Nitrosamine impurity analysis with LC-MS/MS: Dr Anoop Kumar, Head, Market Development and Marketing, SCIEX Read more
Measures to build a culture of quality and compliance in pharma industry: Dr Deo Narain Dikshit, Consultant,Pharma Quality, Compliance and Manufacturing process, Aqex Pharma Solutions Read more